Bruce Baron

Chronic hypopituitarism was noted in 44% of US veterans with mild traumatic brain injury.

Participants were 6 times more likely to develop the disease if they had depression and metabolic risk factors.

The temporary 1-year intestinal bypass device with liraglutide boosts weight loss and improves diabetes control.

Sleeve with ileal transposition surgery resulted in better glycemic control in mildly obese patients with diabetes.

Risk for asthma was increased by 34% in women with polycystic ovary syndrome.

Serum anti-Müllerian hormone levels may help identify women who may lose bone mass the fastest.

A 3D-printed ovarian prosthesis restored the female hormone cycle and supported natural ovulation in mice.

Neuropathy, albuminuria, and metabolic syndrome components were prevalent in people with youth-onset diabetes.

Adolescents with autism spectrum disorder appear to be more likely to develop the disease.

Health care costs associated with endocrine-disrupting chemicals exceed €1 billion in the European Union.

Aflibercept improved visual acuity more than bevacizumab in diabetic macular edema, but only in patients with worse vision.

Sexual function and mood and depressive symptoms were improved in older men who received testosterone therapy.

Sedentary lifestyles were common among middle-aged Hispanic women and were also associated with worse menopausal symptoms.

Women with sleeping disorders may face a greater risk for type 2 diabetes.

Eating soy regularly may protect women who are undergoing infertility treatment from poor success due to BPA exposure.

Mental health conditions, like binge eating disorder and depression, are common among patients undergoing bariatric surgery.

Children conceived through infertility treatment are no more likely to experience developmental delays than those conceived without the treatment.

Both high- and low-dose adrenocorticotropic hormone stimulation tests are adequate for including adrenal insufficiency as a diagnosis.

Common vulvovaginal symptoms can have emotional, lifestyle, and sexual effects in postmenopausal women.

Patients with thyroid cancer report worse quality of life than others diagnosed with more lethal cancers.

The FDA has lifted the Risk Evaluation and Mitigation Strategy placed on rosiglitazone-containing medications.

High levels of testosterone and estrogen may raise a woman’s risk for uterine fibroids.

The FDA warns of risks for ketoacidosis and serious urinary tract infections with use of SGLT2 inhibitors.

Progesterone therapy during the first trimester did not increase live birth rates in women with recurrent miscarriages.

Results from the SPRINT trial suggest that a systolic blood pressure target of 120 mm Hg instead of 140 mm Hg may prevent CV events.

Disclosing genetic risk information resulted in lower LDL cholesterol levels in patients at risk for coronary heart disease.

Results from the Fifty-Fifty trial demonstrated the success of peer support in reducing cardiovascular risk factors.

Liraglutide failed to improve clinical stability in patients with advanced HF and reduced LVEF.

Increased HDL cholesterol during menopausal transition linked to greater carotid intima-media thickness.

Children with high blood pressure more likely to develop heart disease by age 38.